What is Copaxone 40 mg?
COPAXONE® (glatiramer acetate injection) is used to treat relapsing forms of multiple sclerosis (MS). It is a subcutaneous injection made with a nonpyrogenic solution, 20 mg or 40 mg of glatiramer acetate, and 40 mg of the inactive ingredient mannitol.
Is Copaxone a good MS medication?
Copaxone blocks T cells that can damage the myelin. It can also lower the number of relapses you have and make the ones you do have less severe. Copaxone is an option for people who have one of these types of relapsing MS: Clinically isolated syndrome.
What type of MS is Copaxone used for?
Teva Neuroscience, Inc. COPAXONE® is a prescription medicine that is used to treat relapsing forms of multiple sclerosis (MS), to include clinically isolated syndrome, relapsing-remitting disease, and active secondary progressive disease, in adults.
Is glatiramer acetate the same as Copaxone?
Glatopa is not a generic version of the 40mg dose of Copaxone taken every three days. Glatiramer acetate is a synthetic protein that mimics myelin basic protein, a component of the myelin that insulates nerve fibers in the brain and spinal cord.
How long can you stay on Copaxone?
Copaxone is considered a long-term (life-long) treatment and should be administered for as long as it is effective or tolerated. Copaxone has shown to significantly reduce the number of relapses in people with MS. 34 to 56% were relapse-free after two years.
How much does Copaxone cost per month?
More than 70% of COPAXONE® patients pay less than $10 per month out of pocket. Receive a co-pay card for COPAXONE® to use when filling your prescription or refills, subject to applicable program restrictions.
Why does Copaxone hurt so much?
Injection site reactions, such as lumps or pain The most common side effects of Copaxone are skin reactions that occur at the injection sites. These reactions may cause bruising, redness, swelling, lumps, pain, or itching.
Is there a generic for Copaxone 40 mg?
The U.S. Food and Drug Administration has approved a second generic form of 40mg glatiramer acetate injection, called Glatopa® (Sandoz). This is a generic form of 40mg Copaxone® (Teva Pharmaceutical Industries LTD), taken three days per week by injections under the skin to treat relapsing forms of MS.
What are the long term side effects of Copaxone?
Yes, some side effects of Copaxone may be long term. For example, it’s possible to have skin damage in the places where you inject Copaxone. * While this isn’t common, it can cause permanent pitting of the skin in those areas.
Does Copaxone make you gain weight?
Some people taking Copaxone have had weight gain. In clinical studies, 3% of people who took the drug gained weight. In comparison, 1% of people who took a placebo (treatment with no active drug) gained weight. However, weight gain can also be related to multiple sclerosis (MS), which Copaxone is used to treat.
Is generic Copaxone The same as Copaxone?
Glatopa is an FDA-approved generic substitute for COPAXONE® (glatiramer acetate injection). This means that Glatopa: Has the same active ingredient and dosage strength options. Meets the same FDA quality standards.
What is the composition of Copaxone 40 mg/mL?
Copaxone 40 mg/ml solution for injection in pre-filled syringe 2. Qualitative and quantitative composition 1 pre-filled syringe (1 ml) of solution for injection contains 40 mg glatiramer acetate*, equivalent to 36 mg of glatiramer.
What kind of syringe do you use for Copaxone 40 mg?
A pre-filled syringe containing Copaxone 40 mg/ml solution for injection consists of a 1 ml colourless type I glass syringe barrel with staked needle, a blue polypropylene (optional polystyrene) plunger rod, a rubber plunger stopper and a needle shield.
Can Copaxone 40 mg/mL Tiw be given subcutaneously?
Therefore, Copaxone 40 mg/ml TIW should not be used in this population. Copaxone is for subcutaneous use. Patients should be instructed in self-injection techniques and should be supervised by a healthcare professional the first time they self-inject and for 30 minutes after.
Does Copaxone affect the distribution of proteins?
Nevertheless, as Copaxone has, theoretically, the potential to affect the distribution of protein-bound substances, concomitant use of such medicinal products should be monitored carefully. Studies in animals have not shown reproductive toxicity (see section 5.3).